Pregnancy: Salbutamol + Beclometasone dipropionate (Ibicar S) is not recommended for use in the first three months of pregnancy. The decision of administration to the patient should be weighed against the risk/benefit.
Animal studies have not demonstrated fetal risk, but there are no controlled studies in pregnant women.
Lactation: Not recommended for use during lactation.
There is no experience or data on the safety of propellant HFA-134a in pregnancy or lactation in humans. However, studies on the effects of HFA-134a on reproductive function and embryonic development in animals have shown no clinically significant adverse effects.
Therefore, it is unlikely that adverse effects occur in humans.
This medicine should not be used by pregnant women without advice from their physician.